GH (Oxylife Nutritional Supplements Inc)
Welcome to the PulseAid listing for the GH drug offered from Oxylife Nutritional Supplements Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Oxylife Nutritional Supplements Inc |
NON-PROPRIETARY NAME: | Human Growth Hormone, Pituitaria Glandula, Hepar Suis |
SUBSTANCE NAME: | SOMATROPIN; SUS SCROFA PITUITARY GLAND; PORK LIVER |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | SPRAY |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2014-07-14 |
END MARKETING DATE: | 0000-00-00 |
GH HUMAN OTC DRUG Details:
Item Description | GH from Oxylife Nutritional Supplements Inc |
LABELER NAME: | Oxylife Nutritional Supplements Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 30; 30; 6([hp_X]/mL; [hp_X]/mL; [hp_X]/mL) |
START MARKETING DATE: | 2014-07-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 49295-0001_2d9d93ea-a9c4-4601-aacd-eeba8efe2728 |
PRODUCT NDC: | 49295-0001 |
APPLICATION NUMBER: | |
Other SOMATROPIN; SUS SCROFA PITUITARY GLAND; PORK LIVER Pharmaceutical Manufacturers / Labelers: